FDA, DEA Blame Demand, Drug Makers for ADHD Med Shortage FDA, DEA Blame Demand, Drug Makers for ADHD Med Shortage

In a letter to the public the FDA and the DEA contend that unprecedented demand, potential overprescribing, and underproduction are the primary reasons for the national shortage of stimulants to treat ADHD.Medscape Medical News
Source: Medscape Psychiatry Headlines - Category: Psychiatry Tags: Psychiatry News Source Type: news
More News: ADHD | Psychiatry